Synopsis
Interpret every full-blood-count lineage in clinical context, recognise dangerous patterns and artefacts, and move from an abnormal number to a proportionate confirmatory and referral plan.
- Read haemoglobin, white-cell differential and platelets together before focusing on a flagged value; abnormalities across several lineages suggest marrow, infiltrative, consumptive or systemic disease rather than an isolated deficiency.
- Compare with the patient's baseline and the laboratory's age-, sex- and pregnancy-appropriate reference interval. Direction and speed of change often carry more clinical information than a single result just outside range.
- For anaemia, begin with mean cell volume, mean cell haemoglobin, red-cell distribution width and reticulocytes, then integrate film, iron studies, B12, folate, renal, inflammatory and haemolysis testing as the phenotype directs.
- Use absolute neutrophil, lymphocyte, eosinophil, basophil and monocyte counts rather than percentages. A normal total white count can conceal a clinically important differential-count abnormality.
- Confirm unexpected thrombocytopenia on a fresh citrate or otherwise laboratory-advised sample and film when platelet clumping is possible, while examining for bleeding, sepsis, drugs and thrombotic microangiopathy.
- A machine flag is a request for review, not a diagnosis. Blasts, nucleated red cells, schistocytes, atypical lymphocytes and platelet clumps need skilled film correlation and clinical context.
- Do not use the full blood count as a cancer rule-out test. Persistent lymphadenopathy, splenomegaly, weight loss, unexplained bleeding or recurrent infection can require investigation despite initially normal counts.
- Close the loop on critical laboratory calls: verify identity and sampling, assess the patient, compare prior results, repeat only when useful, and record who will act on film, culture, haematinic or referral results.
Key red flags
Anaemia plus neutropenia and thrombocytopenia raises marrow failure, infiltration, acute leukaemia, severe deficiency, sepsis, hypersplenism or treatment toxicity. Fever, bleeding or blasts makes the pattern urgent.
Blasts, promyelocytes with coagulopathy, schistocytes with thrombocytopenia, profound neutropenia with fever, or active bleeding with severe thrombocytopenia requires same-hour clinical and haematology escalation.
Investigation priorities
Confirm an unexpected abnormality and establish its trajectory across all lineages.
Management branches
The patient is unwell, bleeding or febrile, or the report shows blasts, severe cytopenia, fragmentation or a critical laboratory alert.
- Assess ABCDE, confirm symptoms and observations, inspect for bleeding or infection, obtain urgent repeat and film samples where this causes no harmful delay, and contact senior haematology.
- Use the supported emergency pathway: preferred management is immediate neutropenic-sepsis treatment for fever with significant neutropenia, a TTP pathway for microangiopathic haemolysis, or an acute-leukaemia pathway for blasts or abnormal promyelocytes.
- Escalate active major bleeding, haemodynamic compromise, neurological change or suspected disseminated coagulopathy to critical care and transfusion support; do not wait for a complete outpatient investigation panel.